Tomorrow’s a Big Day for FDA

Tomorrow, Congress will vote on user fees and other aspects of a bill proposed by Senators Kennedy and Enzi.  Here, an update from Bloomberg's Lindsay Arendt, which includes an interview with PhRMA's Dr. Alan Goldhammer and former FDA Commissioner Dr. Mark McClelland.

Play Video

Former Commissioner McClelland: FDA Needs Appropriations - A Report on Tomorrow's Vote and What it Could Mean for the Agency

Bloomberg - (BLOOM)

Apr. 17, 2007. 05:42 PM EST

Tomorrow will be a big day for FDA, when the Congressional health committee votes on PDUFA and drug safety. The Kennedy-Enzi bill will increase user fees by 51%, limit direct-to-consumer advertising, and require increased disclosure of clinical trial results